Breast Cancer

Afanat (Afatinib 30 mg Tablets) is a prescription medication used for the treatment of certain types of non-small cell lung cancer (NSCLC). Afatinib is a tyrosine kinase inhibitor that works by blocking the activity of proteins involved in the growth and spread of cancer cells.

Indications:

Afanat is indicated for the treatment of:

• First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
• Treatment of patients with metastatic squamous NSCLC progressing after platinum-based chemotherapy.

How to Use:

• Take Afanat exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a full glass of water.
• Do not crush, chew, or break the tablet.
• It should be taken on an empty stomach, at least 1 hour before or 2 hours after eating.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Afanat may include:

• Diarrhea
• Skin rash
• Mouth sores
• Dry skin
• Nail inflammation
• Decreased appetite

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring may be required to manage side effects and ensure the effectiveness of the treatment.
• Use effective contraception to avoid pregnancy while taking Afanat, as it may harm an unborn baby.
• Afanat is not recommended for use in breastfeeding women.

Storage:

• Store Afanat tablets at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the tablets in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

Palnat (Palbociclib 125 mg Capsules) is a prescription medication used for the treatment of certain types of breast cancer. Palbociclib is a cyclin-dependent kinase (CDK) 4/6 inhibitor that works by blocking proteins involved in cell division, thereby slowing down the growth and spread of cancer cells.

Indications:

Palnat is indicated for the treatment of:

• Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women.
• HR+, HER2- advanced or metastatic breast cancer in combination with fulvestrant in women with disease progression following endocrine therapy.

How to Use:

• Take Palnat exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or open the capsule.
• It should be taken with food.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Palnat may include:

• Neutropenia (low white blood cell count)
• Infections
• Fatigue
• Nausea
• Stomatitis (inflammation of the mouth)
• Anemia
• Hair thinning or loss
• Diarrhea

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular blood tests may be required to monitor blood cell counts.
• Use effective contraception to avoid pregnancy while taking Palnat, as it may harm an unborn baby.
• Palnat is not recommended for use in breastfeeding women.

Storage:

• Store Palnat capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

ABRAXANE Injectable Suspension (Paclitaxel Protein-Bound Particles) 100 mg Vial is an advanced formulation of paclitaxel, a chemotherapeutic agent used to treat various types of cancer, including metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. Unlike traditional paclitaxel, ABRAXANE uses albumin-bound particles, which enhance the drug’s delivery to cancer cells and improve its efficacy. This formulation allows for higher concentrations of paclitaxel to be administered with a reduced risk of hypersensitivity reactions. Our super specialty pharmacy provides high-quality ABRAXANE with personalized treatment plans and expert support to ensure optimal care for cancer patients. Trust us for effective and comprehensive cancer care tailored to your needs.

TABLE OF CONTENT
Mode of Action
Indications
Dosage and Administration
Precautions
Side Effects

Tucaxen Tucatinib 150 mg Tablet is a cutting-edge medication meticulously engineered to target specific proteins involved in the growth and spread of cancer cells. Each tablet contains 150 mg of tucatinib, a potent tyrosine kinase inhibitor renowned for its efficacy in treating certain types of advanced or metastatic cancers.

Mode of Action: Tucatinib, the active ingredient in Tucaxen Tucatinib 150 mg Tablet, selectively inhibits the activity of human epidermal growth factor receptor 2 (HER2) and tyrosine kinase, key drivers of cancer cell proliferation and survival. By disrupting these signaling pathways, tucatinib helps suppress tumor growth and metastasis.

Indications: Tucaxen Tucatinib 150 mg Tablet is indicated for the treatment of:

• HER2-Positive Metastatic Breast Cancer
• HER2-Positive Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

Dosage and Administration: The recommended dosage of Tucaxen Tucatinib 150 mg Tablet is one tablet (150 mg) to be taken orally twice daily with or without food. The dosage may vary based on individual patient factors and concurrent treatments. Patients should adhere strictly to the prescribed regimen provided by a healthcare professional.

Precautions:

• Prior to initiating treatment with Tucaxen Tucatinib 150 mg Tablet, patients should undergo thorough medical evaluation, including assessment of cardiac function and liver enzymes.
• Close monitoring of cardiac function, liver function, and gastrointestinal symptoms is essential during therapy.
• Tucatinib may interact with certain medications, so patients should inform their healthcare provider about all concurrent medications, including over-the-counter drugs and herbal supplements.

Side Effects: Common side effects associated with Tucaxen Tucatinib 150 mg Tablet may include:

• Diarrhea
• Nausea
• Fatigue
• Vomiting
• Elevated liver enzymes
• Decreased appetite
• Hand-foot syndrome (palmar-plantar erythrodysesthesia)